FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Dr Reddys Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500124 NSE Symbol: DRREDDY P/E (TTM) :18.62
ISIN Demat:INE089A01031 Div & Yield %:0.69 EPS (TTM) :62.12
Book Value (RS) :322.4611705 Market Cap (Rs Cr.):96496.42 Face Value (RS) :1
    Change Company 
Particulars Quarter Ended
(Mar 2025)		 Quarter Ended
(Mar 2024)		 Quarter Ended
(% Var)
Sales 5,546.30 5,081.80 9.14
Other Income 414.40 212.70 94.83
PBIDT 1,857.40 1,591.30 16.72
Interest 31.10 5.90 427.12
PBDT 1,826.30 1,585.40 15.19
Depreciation 264.50 246.20 7.43
PBT 1,561.80 1,339.20 16.62
Tax 364.30 270.20 34.83
Deferred Tax -3.20 34.20 -109.36
PAT 1,200.70 1,034.80 16.03

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)